|
NDST2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.024400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.230000E-01 |
| Normal-vs-Stage2 |
2.284800E-03 |
| Normal-vs-Stage3 |
3.498000E-02 |
| Normal-vs-Stage4 |
2.984400E-01 |
| Stage1-vs-Stage2 |
2.875400E-03 |
| Stage1-vs-Stage3 |
1.003960E-01 |
| Stage1-vs-Stage4 |
7.312000E-01 |
| Stage2-vs-Stage3 |
9.872400E-02 |
| Stage2-vs-Stage4 |
5.151600E-02 |
| Stage3-vs-Stage4 |
4.213400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.230800E-01 |
| Normal-vs-AfricanAmerican |
2.978800E-01 |
| Normal-vs-Asian |
9.965200E-01 |
| Caucasian-vs-AfricanAmerican |
8.048400E-01 |
| Caucasian-vs-Asian |
2.506400E-01 |
| AfricanAmerican-vs-Asian |
2.995400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.700200E-02 |
| Normal-vs-Female |
1.071990E-01 |
| Male-vs-Female |
7.990000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.964800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.556100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.135500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.968300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.440250E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.740100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.264400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.678000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.468600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.352000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.200000E-02 |
| Classical-VS-Follicular |
2.71980216126622E-11 |
| Classical-VS-Other |
1.860030E-01 |
| Classical-VS-Normal |
8.328000E-01 |
| Tall-VS-Follicular |
2.732200E-02 |
| Tall-VS-Other |
6.949200E-01 |
| Tall-VS-Normal |
8.843800E-02 |
| Follicular-VS-Other |
4.108800E-01 |
| Follicular-VS-Normal |
1.55662999999917E-05 |
| Other-VS-Normal |
1.892010E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.575500E-02 |
| Normal-vs-N1 |
9.863500E-02 |
| N0-vs-N1 |
8.950800E-01 |
|
|
